Login to Your Account

Spinout Cerexa Raises $50M In First Round For PPI-0903

By Karen Pihl-Carey

Wednesday, August 24, 2005
Four months ago Ortho-McNeil Pharmaceuticals Inc. said it was acquiring Peninsula Pharmaceuticals Inc. for $245 million. But the merger left behind Peninsula's lead antibiotic, which went on to become the lead product for spinout Cerexa. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription